Meloni et al., "Cytochrome P450 1A2 Is a Hepatic Autoantigen in Autoimmune Polyglandular
Syndrome Type 1 ," The Journal of Clinical Endocrinology & Metabolism, vol.
Clinical review 93: autoimmune polyglandular
syndrome type 1.
Type 1 diabetes and autoimmune polyglandular
syndrome: a critical review.
She might have a polyglandular
deficiency due to her diagnosis of Graves' hyperthyroidism and diabetes mellitus, i.e.
autoimmune syndromes: immunogenetics and long-term follow-up.
For instance, the company's steroid 21-hydroxylase antibody (21-0HAb) test kit may be useful as an aid in the diagnosis of autoimmune adrenal disease, whether expressed as autoimmune Addison's Disease or Addison's Disease as part of the more complex autoimmune polyglandular
syndrome (APS), Type I or II.
Key Words: Vitiligo, autoimmune polyglandular
syndrome, autoimune thyroiditis, autoimmune gastritis
Vitiligo-asociated autoimmune polyglandular
Other diseases of connection to Sephardi origin include: Alpha-Thalassemia, Ataxia Telangiectasia, Corticosterone Methyloxidase Type II Deficiency, Costeff Optical Atrophy, Cystic Fibrosis (CF), Familial Creutzfeldt-Jakob Disease, Familial Tumoral Calcinosis (Normophosphatemic Type), Inclusion Body Myophy Type 28, Metachromic Leukodystrophy, Polyglandular
Deficiency Syndrome, Pseudocholinesterase Deficiency, Spinal Muscular Athrophy (S.MA) and Wolman Disease.
Premature ovarian failure associated with autoimmune polyglandular
syndrome: pathophysiological mechanism and future fertility.
Classification of the less common types of diabetes mellitus Genetic defect in Beta ([beta]) cells functioning Mitochondrial disorders Late onset diabetes in youth Diseases of the exocrine pancreas Cystic fibrosis-related diabetes Drug-induced diabetes Steroids and chemotherapy drugs Genetic syndromes Prader-Willi, Down, Turner and Wolfram syndromes Endocrine pathologies Cushing and polyglandular
autoimmune syndromes Table modified from Rhodes ET, Ferrari LR, Wolfsdorf JI.
In general, hypothyroidism discovered before the age of three is considered to represent a failure of newborn screening, though cases associated with a rare disease of the endocrine system called polyglandular
autoimmune syndrome have been reported.